642 related articles for article (PubMed ID: 17873029)
1. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum.
Palmer KL; Aye LM; Whiteley M
J Bacteriol; 2007 Nov; 189(22):8079-87. PubMed ID: 17873029
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology.
Palmer KL; Mashburn LM; Singh PK; Whiteley M
J Bacteriol; 2005 Aug; 187(15):5267-77. PubMed ID: 16030221
[TBL] [Abstract][Full Text] [Related]
3. Membrane phospholipid composition of Pseudomonas aeruginosa grown in a cystic fibrosis mucus-mimicking medium.
Deschamps E; Schaumann A; Schmitz-Afonso I; Afonso C; Dé E; Loutelier-Bourhis C; Alexandre S
Biochim Biophys Acta Biomembr; 2021 Jan; 1863(1):183482. PubMed ID: 33002450
[TBL] [Abstract][Full Text] [Related]
4. Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum.
Palmer KL; Brown SA; Whiteley M
J Bacteriol; 2007 Jun; 189(12):4449-55. PubMed ID: 17400735
[TBL] [Abstract][Full Text] [Related]
5. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.
Sajjan US; Tran LT; Sole N; Rovaldi C; Akiyama A; Friden PM; Forstner JF; Rothstein DM
Antimicrob Agents Chemother; 2001 Dec; 45(12):3437-44. PubMed ID: 11709321
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis and bacterial colonization define the sputum N-glycosylation phenotype.
Venkatakrishnan V; Thaysen-Andersen M; Chen SC; Nevalainen H; Packer NH
Glycobiology; 2015 Jan; 25(1):88-100. PubMed ID: 25190359
[TBL] [Abstract][Full Text] [Related]
7. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
[TBL] [Abstract][Full Text] [Related]
8. Bacterial cyanogenesis occurs in the cystic fibrosis lung.
Sanderson K; Wescombe L; Kirov SM; Champion A; Reid DW
Eur Respir J; 2008 Aug; 32(2):329-33. PubMed ID: 18480103
[TBL] [Abstract][Full Text] [Related]
9. Proteomics of Pseudomonas aeruginosa Australian epidemic strain 1 (AES-1) cultured under conditions mimicking the cystic fibrosis lung reveals increased iron acquisition via the siderophore pyochelin.
Hare NJ; Soe CZ; Rose B; Harbour C; Codd R; Manos J; Cordwell SJ
J Proteome Res; 2012 Feb; 11(2):776-95. PubMed ID: 22054071
[TBL] [Abstract][Full Text] [Related]
10. The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa.
Barth AL; Pitt TL
J Med Microbiol; 1996 Aug; 45(2):110-9. PubMed ID: 8683546
[TBL] [Abstract][Full Text] [Related]
11. Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum.
Vermilyea DM; Crocker AW; Gifford AH; Hogan DA
J Bacteriol; 2021 Jun; 203(13):e0010021. PubMed ID: 33927050
[TBL] [Abstract][Full Text] [Related]
12. Poly-L-Lysine compacts DNA, kills bacteria, and improves protease inhibition in cystic fibrosis sputum.
Dubois AV; Midoux P; Gras D; Si-Tahar M; Bréa D; Attucci S; Khelloufi MK; Ramphal R; Diot P; Gauthier F; Hervé V
Am J Respir Crit Care Med; 2013 Sep; 188(6):703-9. PubMed ID: 23947381
[TBL] [Abstract][Full Text] [Related]
13. Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum.
Turner KH; Wessel AK; Palmer GC; Murray JL; Whiteley M
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4110-5. PubMed ID: 25775563
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung.
Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970
[TBL] [Abstract][Full Text] [Related]
15. Secretome of transmissible Pseudomonas aeruginosa AES-1R grown in a cystic fibrosis lung-like environment.
Scott NE; Hare NJ; White MY; Manos J; Cordwell SJ
J Proteome Res; 2013 Dec; 12(12):5357-69. PubMed ID: 23991618
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa Cell Membrane Protein Expression from Phenotypically Diverse Cystic Fibrosis Isolates Demonstrates Host-Specific Adaptations.
Kamath KS; Pascovici D; Penesyan A; Goel A; Venkatakrishnan V; Paulsen IT; Packer NH; Molloy MP
J Proteome Res; 2016 Jul; 15(7):2152-63. PubMed ID: 27246823
[TBL] [Abstract][Full Text] [Related]
17. Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum.
Fung C; Naughton S; Turnbull L; Tingpej P; Rose B; Arthur J; Hu H; Harmer C; Harbour C; Hassett DJ; Whitchurch CB; Manos J
J Med Microbiol; 2010 Sep; 59(Pt 9):1089-1100. PubMed ID: 20522626
[TBL] [Abstract][Full Text] [Related]
18. Two NAD-independent l-lactate dehydrogenases drive l-lactate utilization in Pseudomonas aeruginosa PAO1.
Wang Y; Xiao D; Liu Q; Zhang Y; Hu C; Sun J; Yang C; Xu P; Ma C; Gao C
Environ Microbiol Rep; 2018 Oct; 10(5):569-575. PubMed ID: 30066495
[TBL] [Abstract][Full Text] [Related]
19. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.
Perry JD; Laine L; Hughes S; Nicholson A; Galloway A; Gould FK
J Antimicrob Chemother; 2008 May; 61(5):1057-61. PubMed ID: 18316821
[TBL] [Abstract][Full Text] [Related]
20. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
Aichele D; Schnare M; Saake M; Röllinghoff M; Gessner A
Infect Immun; 2006 Aug; 74(8):4708-14. PubMed ID: 16861658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
